Literature DB >> 3983339

Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.

S G Potkin, Y C Shen, D F Zhou, H Pardes, L Shu, B Phelps, R Poland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3983339

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  8 in total

1.  Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia.

Authors:  M W Kelly; P J Perry; W H Coryell; D D Miller; S V Arndt
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment?

Authors:  W H Chang
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.

Authors:  S Ulrich; C Wurthmann; M Brosz; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 4.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

5.  Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia.

Authors:  R C Smith; R Baumgartner; A Shvartsburd; G K Ravichandran; G Vroulis; M Mauldin
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 7.  Pharmacokinetics of haloperidol.

Authors:  J S Froemming; Y W Lam; M W Jann; C M Davis
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

8.  Clinical considerations on neuroleptic malignant syndrome.

Authors:  G B Palermo
Journal:  J R Soc Med       Date:  1991-08       Impact factor: 18.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.